For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...
According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast- conserving ... according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held ...
Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...
An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...
DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.